Philippines Hyperglycemics Research
7 comprehensive market analysis studies and research reports on the Philippines Hyperglycemics sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 79 companies, enriched with industry statistics, insights, and a lot more.
TRENDING REPORTS
Insulin Market
CAGR: 3.62%
Study Period : 2020 - 2031
Middle East And Africa Insulin Market
CAGR: 3.73%
Study Period : 2020 - 2031
SGLT2 Market
CAGR: 8.05%
Study Period : 2020 - 2031
Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market
CAGR: 4.27%
Study Period : 2020 - 2031
North America Insulin Market
CAGR: 3.91%
Study Period : 2019 - 2030
Healthcare
Categories
7 Healthcare Reports
Categories
Showing 7 of 7 results in Hyperglycemics
APAC Meglitinide Market
CAGR: 1.7%
Study Period: 2019 - 2030
Country Covered: Philippines
Major Players:Novo Nordisk, Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon
APAC Biguanide Market
CAGR: 2%
Study Period: 2019 - 2030
Country Covered: Philippines
Major Players:Takeda Pharmaceuticals, Bristol-Myers Squibb, Glenmark Pharmaceuticals, Merck, Sanofi
Basal Insulin Market
CAGR: 4.70%
Study Period: 2019 - 2030
Country Covered: Philippines
Major Players:Novo Nordisk, Sanofi, Eli Lilly and Company, Biocon, Wockhardt
TRENDING REPORTS
Insulin Market
CAGR: 3.62%
Study Period : 2020 - 2031
Middle East And Africa Insulin Market
CAGR: 3.73%
Study Period : 2020 - 2031
SGLT2 Market
CAGR: 8.05%
Study Period : 2020 - 2031
Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market
CAGR: 4.27%
Study Period : 2020 - 2031
North America Insulin Market
CAGR: 3.91%
Study Period : 2019 - 2030
Sulfonylureas Market
CAGR: 3.12%
Study Period: 2019 - 2030
Country Covered: Philippines
Major Players:Sanofi, Pfizer, Merck, Torrent Pharmaceuticals, Dr. Reddy’s Laboratories
Meglitinide Market
CAGR: 2.21%
Study Period: 2019 - 2030
Country Covered: Philippines
Major Players:Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon, Novo Nordisk
Asia-Pacific Sodium-dependent Glucose Cotransporter 2 Market
CAGR: 7.94%
Study Period: 2020 - 2031
Country Covered: Philippines
Major Players:Eli Lilly and Company, Boehringer Ingelheim, Janssen, AstraZeneca, Bristol-Myers Squibb
Asia-Pacific Insulin Therapeutics Market
CAGR: 2.54%
Study Period: 2019 - 2030
Country Covered: Philippines
Major Players:Novo Nordisk, Eli Lilly and Company, Sanofi, Biocon, Gan & Lee
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
